Mozambique vs Nigeria: Population requiring preventive chemotherapy for schistosomiasis
Mozambique
18.41 million
in 2024
Nigeria
34.86 million
in 2024
Mozambique rank
4th
Nigeria rank
1st
Population requiring preventive chemotherapy for schistosomiasis over time
- Mozambique
- Nigeria
How they compare
Nigeria currently reports 34.86 million against 18.41 million in Mozambique, a difference of 16.45 million.
That makes Nigeria's figure about 1.9 times Mozambique's.
Across all 15 years both countries report, Nigeria has been ahead every year.
Mozambique ranks 4th and Nigeria ranks 1st of 52 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mozambique | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13.93 million | 43.26 million | 29.33 million | Nigeria |
| 2020s | 18.10 million | 30.07 million | 11.97 million | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Mozambique or Nigeria?
- Nigeria, at 34.86 million against 18.41 million in Mozambique as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Mozambique and Nigeria?
- 16.45 million, with Nigeria ahead.
- How many years of comparable data are there for Mozambique and Nigeria?
- 15 years are reported by both, from 2010 to 2024.
- How do Mozambique and Nigeria rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Mozambique ranks 4th and Nigeria ranks 1st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.